Immunotherapy of Food Allergy: a Comprehensive Review

1.

Sicherer SH, Sampson HA (2014) Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol 133:291–307. https://doi.org/10.1016/j.jaci.2013.11.020 CrossRefPubMed

2.

Wawrzyniak P, Akdis CA, Finkelman FD, Rothenberg ME (2016) Advances and highlights in mechanisms of allergic disease in 2015. J Allergy Clin Immunol 137:1681–1696. https://doi.org/10.1016/j.jaci.2016.02.010 CrossRefPubMed

3.

Ho MH, Wong WH, Chang C (2014) Clinical spectrum of food allergies: a comprehensive review. Clin Rev Allergy Immunol 46:225–240. https://doi.org/10.1007/s12016-012-8339-6 CrossRefPubMed

4.

Uppal V, Kreiger P, Kutsch E (2016) Eosinophilic gastroenteritis and colitis: a comprehensive review. Clin Rev Allergy Immunol 50:175–188. https://doi.org/10.1007/s12016-015-8489-4 CrossRefPubMed

5.

Kumar A, Teuber SS, Naguwa S, Prindiville T, Gershwin ME (2006) Eosinophilic gastroenteritis and citrus-induced urticaria. Clin Rev Allergy Immunol 30:61–70. https://doi.org/10.1385/CRIAI:30:1:061 CrossRefPubMed

6.

Bock SA, Atkins FM (1989) The natural history of peanut allergy. J Allergy Clin Immunol 83:900–904CrossRefPubMed

7.

Longo G, Barbi E, Berti I, Meneghetti R, Pittalis A, Ronfani L, Ventura A (2008) Specific oral tolerance induction in children with very severe cow’s milk-induced reactions. J Allergy Clin Immunol 121:343–347. https://doi.org/10.1016/j.jaci.2007.10.029 CrossRefPubMed

8.

Nelson HS, Lahr J, Rule R, Bock A, Leung D (1997) Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 99:744–751CrossRefPubMed

9.

Pajno GB, Caminiti L, Ruggeri P, De Luca R, Vita D, La Rosa M, Passalacqua G (2010) Oral immunotherapy for cow’s milk allergy with a weekly up-dosing regimen: a randomized single-blind controlled study. Ann Allergy Asthma Immunol 105:376–381. https://doi.org/10.1016/j.anai.2010.03.015 CrossRefPubMed

10.

Patriarca G, Nucera E, Roncallo C et al (2003) Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 17:459–465CrossRefPubMed

11.

Salmivesi S, Korppi M, Makela MJ, Paassilta M (2013) Milk oral immunotherapy is effective in school-aged children. Acta Paediatr 102:172–176. https://doi.org/10.1111/j.1651-2227.2012.02815.x CrossRefPubMed

12.

Skripak JM, Nash SD, Rowley H, Brereton NH, Oh S, Hamilton RG, Matsui EC, Burks AW, Wood RA (2008) A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol 122:1154–1160. https://doi.org/10.1016/j.jaci.2008.09.030 CrossRefPubMedPubMedCentral

13.

Burks AW, Shin D, Cockrell G, Stanley JS, Helm RM, Bannon GA (1997) Mapping and mutational analysis of the IgE-binding epitopes on Ara h 1, a legume vicilin protein and a major allergen in peanut hypersensitivity. Eur J Biochem 245:334–339CrossRefPubMed

14.

Al-Muhsen S, Clarke AE, Kagan RS (2003) Peanut allergy: an overview. CMAJ 168:1279–1285PubMedPubMedCentral

15.

Burks AW, Cockrell G, Stanley JS, Helm RM, Bannon GA (1995) Recombinant peanut allergen Ara h I expression and IgE binding in patients with peanut hypersensitivity. J Clin Invest 96:1715–1721. https://doi.org/10.1172/JCI118216 CrossRefPubMedPubMedCentral

16.

Shin DS, Compadre CM, Maleki SJ, Kopper RA, Sampson H, Huang SK, Burks AW, Bannon GA (1998) Biochemical and structural analysis of the IgE binding sites on ara h1, an abundant and highly allergenic peanut protein. J Biol Chem 273:13753–13759CrossRefPubMed

17.

Palmer GW, Dibbern DA Jr, Burks AW, Bannon GA, Bock SA, Porterfield HS, McDermott RA, Dreskin SC (2005) Comparative potency of Ara h 1 and Ara h 2 in immunochemical and functional assays of allergenicity. Clin Immunol 115:302–312. https://doi.org/10.1016/j.clim.2005.02.011 CrossRefPubMed

18.

Stanley JS, King N, Burks AW, Huang SK, Sampson H, Cockrell G, Helm RM, West CM, Bannon GA (1997) Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys 342:244–253. https://doi.org/10.1006/abbi.1997.9998 CrossRefPubMed

19.

Koppelman SJ, Knol EF, Vlooswijk RA, Wensing M, Knulst AC, Hefle SL, Gruppen H, Piersma S (2003) Peanut allergen Ara h 3: isolation from peanuts and biochemical characterization. Allergy 58:1144–1151CrossRefPubMed

20.

Breiteneder H, Radauer C (2004) A classification of plant food allergens. J Allergy Clin Immunol 113:821–830. https://doi.org/10.1016/j.jaci.2004.01.779 CrossRefPubMed

21.

Kleber-Janke T, Crameri R, Appenzeller U, Schlaak M, Becker WM (1999) Selective cloning of peanut allergens, including profilin and 2S albumins, by phage display technology. Int Arch Allergy Immunol 119:265-274. doi:24203

22.

Mittag D, Akkerdaas J, Ballmer-Weber BK et al (2004) Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy. J Allergy Clin Immunol 114:1410–1417. https://doi.org/10.1016/j.jaci.2004.09.014 CrossRefPubMed

23.

Krause S, Reese G, Randow S et al (2009) Lipid transfer protein (Ara h 9) as a new peanut allergen relevant for a Mediterranean allergic population. J Allergy Clin Immunol 124:771–778. https://doi.org/10.1016/j.jaci.2009.06.008 CrossRefPubMed

24.

Lauer I, Dueringer N, Pokoj S et al (2009) The non-specific lipid transfer protein, Ara h 9, is an important allergen in peanut. Clin Exp Allergy 39:1427–1437. https://doi.org/10.1111/j.1365-2222.2009.03312.x CrossRefPubMed

25.

Pons L, Chery C, Romano A, Namour F, Artesani MC, Gueant JL (2002) The 18 kDa peanut oleosin is a candidate allergen for IgE-mediated reactions to peanuts. Allergy 57(Suppl 72):88–93CrossRefPubMed

26.

Petersen A, Kull S, Rennert S et al (2015) Peanut defensins: novel allergens isolated from lipophilic peanut extract. J Allergy Clin Immunol 136:1295–1301. https://doi.org/10.1016/j.jaci.2015.04.010 CrossRefPubMed

27.

Willison LN, Sathe SK, Roux KH (2014) Production and analysis of recombinant tree nut allergens. Methods 66:34–43. https://doi.org/10.1016/j.ymeth.2013.07.033 CrossRefPubMed

28.

Shewry PR, Napier JA, Tatham AS (1995) Seed storage proteins: structures and biosynthesis. Plant Cell 7:945–956. https://doi.org/10.1105/tpc.7.7.945 CrossRefPubMedPubMedCentral

29.

Diaz-Perales A, Collada C, Blanco C, Sanchez-Monge R, Carrillo T, Aragoncillo C, Salcedo G (1998) Class I chitinases with hevein-like domain, but not class II enzymes, are relevant chestnut and avocado allergens. J Allergy Clin Immunol 102:127–133CrossRefPubMed

30.

Kos T, Hoffmann-Sommergruber K, Ferreira F et al (1993) Purification, characterization and N-terminal amino acid sequence of a new major allergen from European chestnut pollen—Cas s 1. Biochem Biophys Res Commun 196:1086–1092CrossRefPubMed

31.

Pastorello EA, Robino AM (2004) Clinical role of lipid transfer proteins in food allergy. Mol Nutr Food Res 48:356–362. https://doi.org/10.1002/mnfr.200400047 CrossRefPubMed

32.

Schocker F, Luttkopf D, Scheurer S et al (2004) Recombinant lipid transfer protein Cor a 8 from hazelnut: a new tool for in vitro diagnosis of potentially severe hazelnut allergy. J Allergy Clin Immunol 113:141–147. https://doi.org/10.1016/j.jaci.2003.09.013 CrossRefPubMed

33.

Diaz-Perales A, Lombardero M, Sanchez-Monge R, Garcia-Selles FJ, Pernas M, Fernandez-Rivas M, Barber D, Salcedo G (2000) Lipid-transfer proteins as potential plant panallergens: cross-reactivity among proteins of Artemisia pollen, Castanea nut and Rosaceae fruits, with different IgE-binding capacities. Clin Exp Allergy 30:1403–1410CrossRefPubMed

34.

Lauer I, Alessandri S, Pokoj S, Reuter A, Conti A, Vieths S, Scheurer S (2008) Expression and characterization of three important panallergens from hazelnut. Mol Nutr Food Res 52(Suppl 2):S262–S271. https://doi.org/10.1002/mnfr.200700426 CrossRefPubMed

35.

Tawde P, Venkatesh YP, Wang F, Teuber SS, Sathe SK, Roux KH (2006) Cloning and characterization of profilin (Pru du 4), a cross-reactive almond (Prunus dulcis) allergen. J Allergy Clin Immunol 118:915–922. https://doi.org/10.1016/j.jaci.2006.05.028 CrossRefPubMed

36.

Akkerdaas JH, Schocker F, Vieths S et al (2006) Cloning of oleosin, a putative new hazelnut allergen, using a hazelnut cDNA library. Mol Nutr Food Res 50:18–23. https://doi.org/10.1002/mnfr.200500147 CrossRefPubMed

37.

Jost R (1988) Physicochemical treatment of food allergens: application to cow’s milk proteins. Nestle Nutr Workshop Ser 17:187–197

38.

Wal JM (1998) Cow’s milk allergens. Allergy 53:1013–1022CrossRefPubMed

39.

Host A, Husby S, Gjesing B, Larsen JN, Lowenstein H (1992) Prospective estimation of IgG, IgG subclass and IgE antibodies to dietary proteins in infants with cow milk allergy. Levels of antibodies to whole milk protein, BLG and ovalbumin in relation to repeated milk challenge and clinical course of cow milk allergy. Allergy 47:218–229CrossRefPubMed

40.

Fiocchi A, Brozek J, Schunemann H et al (2010) World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) guidelines. World Allergy Organ J 3:57–161. https://doi.org/10.1097/WOX.0b013e3181defeb9 CrossRefPubMedPubMedCentral

41.

Hochwallner H, Schulmeister U, Swoboda I, Spitzauer S, Valenta R (2014) Cow’s milk allergy: from allergens to new forms of diagnosis, therapy and prevention. Methods 66:22–33. https://doi.org/10.1016/j.ymeth.2013.08.005 CrossRefPubMedPubMedCentral

42.

Chokshi NY, Sicherer SH (2015) Molecular diagnosis of egg allergy: an update. Expert Rev Mol Diagn 15:895–906. https://doi.org/10.1586/14737159.2015.1041927 CrossRefPubMed

43.

De Silva C, Dhanapala P, Doran T, Tang ML, Suphioglu C (2016) Molecular and immunological analysis of hen’s egg yolk allergens with a focus on YGP42 (Gal d 6). Mol Immunol 71:152–160. https://doi.org/10.1016/j.molimm.2016.02.005 CrossRefPubMed

44.

Suzuki M, Fujii H, Fujigaki H et al (2010) Lipocalin-type prostaglandin D synthase and egg white cystatin react with IgE antibodies from children with egg allergy. Allergol Int 59:175–183. https://doi.org/10.2332/allergolint.09-OA-0121 CrossRefPubMed

45.

Bernhisel-Broadbent J, Dintzis HM, Dintzis RZ, Sampson HA (1994) Allergenicity and antigenicity of chicken egg ovomucoid (Gal d III) compared with ovalbumin (Gal d I) in children with egg allergy and in mice. J Allergy Clin Immunol 93:1047–1059CrossRefPubMed

46.

Aas K (1969) Antigens and allergens of fish. Int Arch Allergy Appl Immunol 36:152–155CrossRefPubMed

47.

Aas K, Lundkvist U (1973) The radioallergosorbent test with a purified allergen from codfish. Clin Allergy 3:255–261CrossRefPubMed

48.

Elsayed SM, Aas K (1970) Characterization of a major allergen (cod.) chemical composition and immunological properties. Int Arch Allergy Appl Immunol 38:536–548CrossRefPubMed

49.

Swoboda I, Bugajska-Schretter A, Verdino P, Keller W, Sperr WR, Valent P, Valenta R, Spitzauer S (2002) Recombinant carp parvalbumin, the major cross-reactive fish allergen: a tool for diagnosis and therapy of fish allergy. J Immunol 168:4576–4584CrossRefPubMed

50.

Bugajska-Schretter A, Elfman L, Fuchs T, Kapiotis S, Rumpold H, Valenta R, Spitzauer S (1998) Parvalbumin, a cross-reactive fish allergen, contains IgE-binding epitopes sensitive to periodate treatment and Ca2+ depletion. J Allergy Clin Immunol 101:67–74. https://doi.org/10.1016/S0091-6749(98)70195-2 CrossRefPubMed

51.

Lim DL, Neo KH, Yi FC, Chua KY, Goh DL, Shek LP, Giam YC, Van Bever HP, Lee BW (2008) Parvalbumin—the major tropical fish allergen. Pediatr Allergy Immunol 19:399–407. https://doi.org/10.1111/j.1399-3038.2007.00674.x CrossRefPubMed

52.

Perez-Gordo M, Sanchez-Garcia S, Cases B, Pastor C, Vivanco F, Cuesta-Herranz J (2008) Identification of vitellogenin as an allergen in Beluga caviar allergy. Allergy 63:479–480. https://doi.org/10.1111/j.1398-9995.2007.01614.x CrossRefPubMed

53.

Hamada Y, Nagashima Y, Shiomi K (2001) Identification of collagen as a new fish allergen. Biosci Biotechnol Biochem 65:285–291. https://doi.org/10.1271/bbb.65.285 CrossRefPubMed

54.

Sakaguchi M, Toda M, Ebihara T et al (2000) IgE antibody to fish gelatin (type I collagen) in patients with fish allergy. J Allergy Clin Immunol 106:579–584. https://doi.org/10.1067/mai.2000.108499 CrossRefPubMed

55.

Das Dores S, Chopin C, Romano A, Galland-Irmouli AV, Quaratino D, Pascual C, Fleurence J, Gueant JL (2002) IgE-binding and cross-reactivity of a new 41 kDa allergen of codfish. Allergy 57(Suppl 72):84–87CrossRefPubMed

56.

Wang B, Li Z, Zheng L, Liu X, Lin H (2011) Identification and characterization of a new IgE-binding protein in mackerel (Scomber japonicus) by MALDI-TOF-MS. J Ocean Univ China 10:93–98CrossRef

57.

Liu R, Krishnan HB, Xue W, Liu C (2011) Characterization of allergens isolated from the freshwater fish blunt snout bream (Megalobrama amblycephala). J Agric Food Chem 59:458–463. https://doi.org/10.1021/jf103942p CrossRefPubMed

58.

Kuehn A, Hilger C, Lehners-Weber C et al (2013) Identification of enolases and aldolases as important fish allergens in cod, salmon and tuna: component resolved diagnosis using parvalbumin and the new allergens. Clin Exp Allergy 43:811–822. https://doi.org/10.1111/cea.12117 CrossRefPubMed

59.

Shanti KN, Martin BM, Nagpal S, Metcalfe DD, Rao PVS (1993) Identification of tropomyosin as the major shrimp allergen and characterization of its IgE-binding epitopes. J Immunol 151:5354–5363PubMed

60.

Daul CB, Slattery M, Reese G, Lehrer SB (1994) Identification of the major brown shrimp (Penaeus aztecus) allergen as the muscle protein tropomyosin. Int Arch Allergy Immunol 105:49–55CrossRefPubMed

61.

Leung PS, Chu KH, Chow WK, Ansari A, Bandea CI, Kwan HS, Nagy SM, Gershwin ME (1994) Cloning, expression, and primary structure of Metapenaeus ensis tropomyosin, the major heat-stable shrimp allergen. J Allergy Clin Immunol 94:882–890CrossRefPubMed

62.

Reese G, Ayuso R, Lehrer SB (1999) Tropomyosin: an invertebrate pan-allergen. Int Arch Allergy Immunol 119:247-258. doi:24201 [pii] 24201

63.

Leung PS, Chow WK, Duffey S, Kwan HS, Gershwin ME, Chu KH (1996) IgE reactivity against a cross-reactive allergen in crustacea and mollusca: evidence for tropomyosin as the common allergen. J Allergy Clin Immunol 98:954–961CrossRefPubMed

64.

Leung NY, Wai CY, Shu S, Wang J, Kenny TP, Chu KH, Leung PS (2014) Current immunological and molecular biological perspectives on seafood allergy: a comprehensive review. Clin Rev Allergy Immunol 46:180–197. https://doi.org/10.1007/s12016-012-8336-9 CrossRefPubMed

65.

Garcia-Orozco KD, Aispuro-Hernandez E, Yepiz-Plascencia G, Calderon-de-la-Barca AM, Sotelo-Mundo RR (2007) Molecular characterization of arginine kinase, an allergen from the shrimp Litopenaeus vannamei. Int Arch Allergy Immunol 144:23–28. https://doi.org/10.1159/000102610 CrossRefPubMed

66.

Yu CJ, Lin YF, Chiang BL, Chow LP (2003) Proteomics and immunological analysis of a novel shrimp allergen, Pen m 2. J Immunol 170:445–453CrossRefPubMed

67.

Bauermeister K, Wangorsch A, Garoffo LP et al (2011) Generation of a comprehensive panel of crustacean allergens from the North Sea Shrimp Crangon crangon. Mol Immunol 48:1983–1992. https://doi.org/10.1016/j.molimm.2011.06.216 CrossRefPubMed

68.

Ayuso R, Grishina G, Ibanez MD, Blanco C, Carrillo T, Bencharitiwong R, Sanchez S, Nowak-Wegrzyn A, Sampson HA (2009) Sarcoplasmic calcium-binding protein is an EF-hand-type protein identified as a new shrimp allergen. J Allergy Clin Immunol 124:114–120. https://doi.org/10.1016/j.jaci.2009.04.016 CrossRefPubMed

69.

Shiomi K, Sato Y, Hamamoto S, Mita H, Shimakura K (2008) Sarcoplasmic calcium-binding protein: identification as a new allergen of the black tiger shrimp Penaeus monodon. Int Arch Allergy Immunol 146:91–98. https://doi.org/10.1159/000113512 CrossRefPubMed

70.

Ayuso R, Grishina G, Bardina L, Carrillo T, Blanco C, Ibanez MD, Sampson HA, Beyer K (2008) Myosin light chain is a novel shrimp allergen, Lit v 3. J Allergy Clin Immunol 122:795–802. https://doi.org/10.1016/j.jaci.2008.07.023 CrossRefPubMed

71.

Pedrosa M, Boyano-Martinez T, Garcia-Ara C, Quirce S (2015) Shellfish allergy: a comprehensive review. Clin Rev Allergy Immunol 49:203–216. https://doi.org/10.1007/s12016-014-8429-8 CrossRefPubMed

72.

Leung NYH, Wai CYY, Shu S, Wang J, Kenny TP, Chu KH, Leung PSC (2014) Current immunological and molecular biological perspectives on seafood allergy: a comprehensive review. Clin Rev Allergy Immunol 46:180–197. https://doi.org/10.1007/s12016-012-8336-9 CrossRefPubMed

73.

Wai CYY, Leung NYH, Chu KH, Leung PSC (2012) From molecule studies of allergens to development of immunotherapy of allergies. J Aller Ther 3:124. https://doi.org/10.4172/2155-6121.1000124 CrossRef

74.

Valenta R, Hochwallner H, Linhart B, Pahr S (2015) Food allergies: the basics. Gastroenterology 148:1120–1123. https://doi.org/10.1053/j.gastro.2015.02.006 CrossRefPubMed

75.

Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B (2012) An update on the hyper-IgE syndromes. Arthritis Res Ther 14:228. https://doi.org/10.1186/ar4069 CrossRefPubMedPubMedCentral

76.

Lexmond WS, Goettel JA, Lyons JJ et al (2016) FOXP3+ Tregs require WASP to restrain Th2-mediated food allergy. J Clin Invest 126:4030–4044. https://doi.org/10.1172/JCI85129 CrossRefPubMedPubMedCentral

77.

Kulis M, Wright BL, Jones SM, Burks AW (2015) Diagnosis, management, and investigational therapies for food allergies. Gastroenterology 148:1132–1142. https://doi.org/10.1053/j.gastro.2015.01.034 CrossRefPubMed

78.

Akdis CA, Akdis M (2011) Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 127:18–27. https://doi.org/10.1016/j.jaci.2010.11.030 CrossRefPubMed

79.

Strait RT, Morris SC, Finkelman FD (2006) IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest 116:833–841. https://doi.org/10.1172/JCI25575 CrossRefPubMedPubMedCentral

80.

Uermösi C, Zabel F, Manolova V, Bauer M, Beerli RR, Senti G, Kündig TM, Saudan P, Bachmann MF (2014) IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization. Allergy 69:338–347. https://doi.org/10.1111/all.12327 CrossRefPubMed

81.

Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL (1995) Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177–180. https://doi.org/10.1038/376177a0 CrossRefPubMed

82.

Akdis CA, Akdis M (2009) Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123:735–746. https://doi.org/10.1016/j.jaci.2009.02.030 CrossRefPubMed

83.

Berin MC, Mayer L (2013) Can we produce true tolerance in patients with food allergy? J Allergy Clin Immunol 131:14–22. https://doi.org/10.1016/j.jaci.2012.10.058 CrossRefPubMed

84.

Gorelik L, Fields PE, Flavell RA (2000) Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165:4773–4777CrossRefPubMed

85.

Gorelik L, Constant S, Flavell RA (2002) Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 195:1499–1505CrossRefPubMedPubMedCentral

86.

Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA (2003) IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33:1205–1214. https://doi.org/10.1002/eji.200322919 CrossRefPubMed

87.

Weiner HL (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182:207–214CrossRefPubMed

88.

Taylor A, Akdis M, Joss A et al (2007) IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1. J Allergy Clin Immunol 120:76–83. https://doi.org/10.1016/j.jaci.2007.04.004 CrossRefPubMed

89.

Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204:1757–1764. https://doi.org/10.1084/jem.20070590 CrossRefPubMedPubMedCentral

90.

Mora JR, Iwata M, Eksteen B et al (2006) Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 314:1157–1160. https://doi.org/10.1126/science.1132742 CrossRefPubMed

91.

Noon L (1911) Prophylactic inoculation against hay fever. Lancet 177:1572-1573. doi:https://doi.org/10.1016/S0140-6736(00)78276-6

92.

Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, Leung DY (1992) Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 90:256–262CrossRefPubMed

93.

Meglio P, Bartone E, Plantamura M, Arabito E, Giampietro PG (2004) A protocol for oral desensitization in children with IgE-mediated cow’s milk allergy. Allergy 59:980–987. https://doi.org/10.1111/j.1398-9995.2004.00542.x CrossRefPubMed

94.

Narisety SD, Skripak JM, Steele P, Hamilton RG, Matsui EC, Burks AW, Wood RA (2009) Open-label maintenance after milk oral immunotherapy for IgE-mediated cow’s milk allergy. J Allergy Clin Immunol 124:610–612. https://doi.org/10.1016/j.jaci.2009.06.025 CrossRefPubMedPubMedCentral

95.

Keet CA, Seopaul S, Knorr S, Narisety S, Skripak J, Wood RA (2013) Long-term follow-up of oral immunotherapy for cow’s milk allergy. J Allergy Clin Immunol 132:737–739. https://doi.org/10.1016/j.jaci.2013.05.006 CrossRefPubMedPubMedCentral

96.

Buchanan AD, Green TD, Jones SM et al (2007) Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 119:199–205. https://doi.org/10.1016/j.jaci.2006.09.016 CrossRefPubMed

97.

Burks AW, Jones SM, Wood RA et al (2012) Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 367:233–243. https://doi.org/10.1056/NEJMoa1200435 CrossRefPubMedPubMedCentral

98.

Caminiti L, Pajno GB, Crisafulli G, Chiera F, Collura M, Panasci G, Ruggeri P, Guglielmo F, Passalacqua G (2015) Oral immunotherapy for egg allergy: a double-blind placebo-controlled study, with postdesensitization follow-up. J Allergy Clin Immunol Pract 3:532–539. https://doi.org/10.1016/j.jaip.2015.01.017 CrossRefPubMed

99.

Anagnostou K, Islam S, King Y et al (2014) Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet 383:1297–1304. https://doi.org/10.1016/S0140-6736(13)62301-6 CrossRefPubMedPubMedCentral

100.

Jones SM, Pons L, Roberts JL et al (2009) Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 124:292–300. https://doi.org/10.1016/j.jaci.2009.05.022 CrossRefPubMedPubMedCentral

101.

Varshney P, Jones SM, Scurlock AM et al (2011) A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 127:654–660. https://doi.org/10.1016/j.jaci.2010.12.1111 CrossRefPubMedPubMedCentral

102.

Moran TP, Vickery BP, Burks AW (2013) Oral and sublingual immunotherapy for food allergy: current progress and future directions. Curr Opin Immunol 25:781–787. https://doi.org/10.1016/j.coi.2013.07.011 CrossRefPubMedPubMedCentral

103.

Moingeon P, Mascarell L (2012) Induction of tolerance via the sublingual route: mechanisms and applications. Clin Dev Immunol 2012:623474. https://doi.org/10.1155/2012/623474 CrossRefPubMed

104.

Allam JP, Novak N, Fuchs C, Asen S, Berge S, Appel T, Geiger E, Kochan JP, Bieber T (2003) Characterization of dendritic cells from human oral mucosa: a new Langerhans’ cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol 112:141–148CrossRefPubMed

105.

Allam JP, Peng WM, Appel T, Wenghoefer M, Niederhagen B, Bieber T, Berge S, Novak N (2008) Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 121(368-374):e361. https://doi.org/10.1016/j.jaci.2007.09.045 CrossRef

106.

Mempel M, Rakoski J, Ring J, Ollert M (2003) Severe anaphylaxis to kiwi fruit: Immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol 111:1406–1409CrossRefPubMed

107.

Kerzl R, Simonowa A, Ring J, Ollert M, Mempel M (2007) Life-threatening anaphylaxis to kiwi fruit: protective sublingual allergen immunotherapy effect persists even after discontinuation. J Allergy Clin Immunol 119:507–508. https://doi.org/10.1016/j.jaci.2006.09.041 CrossRefPubMed

108.

Enrique E, Pineda F, Malek T et al (2005) Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 116:1073–1079. https://doi.org/10.1016/j.jaci.2005.08.027 CrossRefPubMed

109.

Enrique E, Malek T, Pineda F, Palacios R, Bartra J, Tella R, Basagana M, Alonso R, Cistero-Bahima A (2008) Sublingual immunotherapy for hazelnut food allergy: a follow-up study. Ann Allergy Asthma Immunol 100:283–284. https://doi.org/10.1016/S1081-1206(10)60456-5 CrossRefPubMed

110.

de Boissieu D, Dupont C (2006) Sublingual immunotherapy for cow’s milk protein allergy: a preliminary report. Allergy 61:1238–1239. https://doi.org/10.1111/j.1398-9995.2006.01196.x CrossRefPubMed

111.

Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A et al (2012) The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 129:448–455. https://doi.org/10.1016/j.jaci.2011.10.023 CrossRefPubMed

112.

Fernandez-Rivas M, Garrido Fernandez S, Nadal JA et al (2009) Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 64:876–883. https://doi.org/10.1111/j.1398-9995.2008.01921.x CrossRefPubMed

113.

Garcia BE, Gonzalez-Mancebo E, Barber D et al (2010) Sublingual immunotherapy in peach allergy: monitoring molecular sensitizations and reactivity to apple fruit and Platanus pollen. J Investig Allergol Clin Immunol 20:514–520PubMed

114.

Kim EH, Bird JA, Kulis M et al (2011) Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol 127:640–646. https://doi.org/10.1016/j.jaci.2010.12.1083 CrossRefPubMedPubMedCentral

115.

Fleischer DM, Burks AW, Vickery BP et al (2013) Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 131:119–127. https://doi.org/10.1016/j.jaci.2012.11.011 CrossRefPubMedPubMedCentral

116.

Mondoulet L, Dioszeghy V, Puteaux E, Ligouis M, Dhelft V, Letourneur F, Dupont C, Benhamou PH (2012) Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice. Clin Transl Allergy 2:22. https://doi.org/10.1186/2045-7022-2-22 CrossRefPubMedPubMedCentral

117.

Senti G, Graf N, Haug S, Ruedi N, von Moos S, Sonderegger T, Johansen P, Kundig TM (2009) Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol 124:997–1002. https://doi.org/10.1016/j.jaci.2009.07.019 CrossRefPubMed

118.

Stoitzner P, Tripp CH, Eberhart A, Price KM, Jung JY, Bursch L, Ronchese F, Romani N (2006) Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A 103:7783–7788. https://doi.org/10.1073/pnas.0509307103 CrossRefPubMedPubMedCentral

119.

Shklovskaya E, O’Sullivan BJ, Ng LG, Roediger B, Thomas R, Weninger W, Fazekas de St Groth B (2011) Langerhans cells are precommitted to immune tolerance induction. Proc Natl Acad Sci U S A 108:18049–18054. https://doi.org/10.1073/pnas.1110076108 CrossRefPubMedPubMedCentral

120.

Gomez de Aguero M, Vocanson M, Hacini-Rachinel F, Taillardet M, Sparwasser T, Kissenpfennig A, Malissen B, Kaiserlian D, Dubois B (2012) Langerhans cells protect from allergic contact dermatitis in mice by tolerizing CD8(+) T cells and activating Foxp3(+) regulatory T cells. J Clin Invest 122:1700–1711. https://doi.org/10.1172/JCI59725 CrossRefPubMedPubMedCentral

121.

Dioszeghy V, Mondoulet L, Dhelft V, Ligouis M, Puteaux E, Benhamou PH, Dupont C (2011) Epicutaneous immunotherapy results in rapid allergen uptake by dendritic cells through intact skin and downregulates the allergen-specific response in sensitized mice. J Immunol 186:5629–5637. https://doi.org/10.4049/jimmunol.1003134 CrossRefPubMed

122.

Dioszeghy V, Mondoulet L, Dhelft V, Ligouis M, Puteaux E, Dupont C, Benhamou PH (2014) The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice. Clin Exp Allergy 44:867–881. https://doi.org/10.1111/cea.12312 CrossRefPubMedPubMedCentral

123.

Tordesillas L, Mondoulet L, Blazquez AB, Benhamou PH, Sampson HA, Berin MC (2017) Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis. J Allergy Clin Immunol 139:189–201. https://doi.org/10.1016/j.jaci.2016.03.057 CrossRefPubMed

124.

Dupont C, Kalach N, Soulaines P, Legoue-Morillon S, Piloquet H, Benhamou PH (2010) Cow’s milk epicutaneous immunotherapy in children: a pilot trial of safety, acceptability, and impact on allergic reactivity. J Allergy Clin Immunol 125:1165–1167. https://doi.org/10.1016/j.jaci.2010.02.029 CrossRefPubMed

125.

Leung NYH, Wai CYY, Shu SA, Chang CC, Chu KH, Leung PSC (2017) Low dose allergen-specific immunotherapy induces tolerance in a murine model of shrimp allergy. Int Arch Allergy Immunol:(in press)

126.

El-Qutob D (2016) Off-label uses of omalizumab. Clin Rev Allergy Immunol 50:84–96. https://doi.org/10.1007/s12016-015-8490-y CrossRefPubMed

127.

Wood RA, Kim JS, Lindblad R, Nadeau K, Henning AK, Dawson P, Plaut M, Sampson HA (2016) A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow’s milk allergy. J Allergy Clin Immunol 137:1103–1110. https://doi.org/10.1016/j.jaci.2015.10.005 CrossRefPubMed

128.

MacGinnitie AJ, Rachid R, Gragg H et al (2017) Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol 139:873–881. https://doi.org/10.1016/j.jaci.2016.08.010 CrossRefPubMed

129.

Macglashan DW Jr, Saini SS (2013) Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation. J Allergy Clin Immunol 132(906-911):e901–e904. https://doi.org/10.1016/j.jaci.2013.04.056 CrossRef

130.

Frischmeyer-Guerrerio PA, Masilamani M, Gu W et al (2017) Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2017.03.028

131.

Rupa P, Nakamura S, Katayama S, Mine Y (2014) Effects of ovalbumin glycoconjugates on alleviation of orally induced egg allergy in mice via dendritic-cell maturation and T-cell activation. Mol Nutr Food Res 58:405–417. https://doi.org/10.1002/mnfr.201300067 CrossRefPubMed

132.

Yang Z, Li Y, Li C, Wang Z (2012) Synthesis of hypoallergenic derivatives of the major allergen Fag t 1 from tartary buckwheat via sequence restructuring. Food Chem Toxicol 50:2675–2680. https://doi.org/10.1016/j.fct.2012.03.039 CrossRefPubMed

133.

Reese G, Ballmer-Weber BK, Wangorsch A, Randow S, Vieths S (2007) Allergenicity and antigenicity of wild-type and mutant, monomeric, and dimeric carrot major allergen Dau c 1: destruction of conformation, not oligomerization, is the roadmap to save allergen vaccines. J Allergy Clin Immunol 119:944–951. https://doi.org/10.1016/j.jaci.2006.11.699 CrossRefPubMed

134.

Bannon GA, Cockrell G, Connaughton C et al (2001) Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int Arch Allergy Immunol 124:70–72. https://doi.org/10.1159/000053672 CrossRefPubMed

135.

Starkl P, Felix F, Krishnamurthy D et al (2012) An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential. Clin Exp Allergy 42:1801–1812. https://doi.org/10.1111/cea.12031 CrossRefPubMedPubMedCentral

136.

Lemon-Mule H, Sampson HA, Sicherer SH, Shreffler WG, Noone S, Nowak-Wegrzyn A (2008) Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol 122:977–983. https://doi.org/10.1016/j.jaci.2008.09.007 CrossRefPubMed

137.

Martos G, Lopez-Exposito I, Bencharitiwong R, Berin MC, Nowak-Wegrzyn A (2011) Mechanisms underlying differential food allergy response to heated egg. J Allergy Clin Immunol 127:990–997. https://doi.org/10.1016/j.jaci.2011.01.057 CrossRefPubMedPubMedCentral

138.

Watanabe H, Toda M, Sekido H, Wellner A, Fujii T, Henle T, Hachimura S, Nakajima-Adachi H (2014) Heat treatment of egg white controls allergic symptoms and induces oral tolerance to ovalbumin in a murine model of food allergy. Mol Nutr Food Res 58:394–404. https://doi.org/10.1002/mnfr.201300205 CrossRefPubMed

139.

Golias J, Schwarzer M, Wallner M et al (2012) Heat-induced structural changes affect OVA-antigen processing and reduce allergic response in mouse model of food allergy. PLoS One 7:e37156. https://doi.org/10.1371/journal.pone.0037156 CrossRefPubMedPubMedCentral

140.

Jimenez-Saiz R, Rupa P, Mine Y (2011) Immunomodulatory effects of heated ovomucoid-depleted egg white in a BALB/c mouse model of egg allergy. J Agric Food Chem 59:13195–13202. https://doi.org/10.1021/jf202963r CrossRefPubMed

141.

Turner PJ, Mehr S, Joshi P, Tan J, Wong M, Kakakios A, Campbell DE (2013) Safety of food challenges to extensively heated egg in egg-allergic children: a prospective cohort study. Pediatr Allergy Immunol 24:450–455. https://doi.org/10.1111/pai.12093 CrossRefPubMed

142.

Goldberg MR, Nachshon L, Appel MY, Elizur A, Levy MB, Eisenberg E, Sampson HA, Katz Y (2015) Efficacy of baked milk oral immunotherapy in baked milk-reactive allergic patients. J Allergy Clin Immunol. https://doi.org/10.1016/j.jaci.2015.05.040

143.

Toda M, Reese G, Gadermaier G et al (2011) Protein unfolding strongly modulates the allergenicity and immunogenicity of Pru p 3, the major peach allergen. J Allergy Clin Immunol 128:1022–1030. https://doi.org/10.1016/j.jaci.2011.04.020 CrossRefPubMed

144.

Bencharitiwong R, van der Kleij HP, Koppelman SJ, Nowak-Wegrzyn A (2015) Effect of chemical modifications on allergenic potency of peanut proteins. Allergy Asthma Proc 36:185–191. https://doi.org/10.2500/aap.2015.36.3840 CrossRefPubMedPubMedCentral

145.

Pree I, Reisinger J, Focke M et al (2007) Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man. J Immunol 179:5309–5316CrossRefPubMed

146.

Hochwallner H, Schulmeister U, Swoboda I et al (2010) Visualization of clustered IgE epitopes on alpha-lactalbumin. J Allergy Clin Immunol 125:1279–1285. https://doi.org/10.1016/j.jaci.2010.03.007 CrossRefPubMed

147.

Mine Y, Rupa P (2003) Fine mapping and structural analysis of immunodominant IgE allergenic epitopes in chicken egg ovalbumin. Protein Eng 16:747–752CrossRefPubMed

148.

Shreffler WG, Lencer DA, Bardina L, Sampson HA (2005) IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol 116:893–899. https://doi.org/10.1016/j.jaci.2005.06.033 CrossRefPubMed

149.

Wai CYY, Leung NYH, Ho MH, Gershwin LJ, Shu SA, Leung PSC, Chu KH (2014) Immunization with hypoallergens of shrimp allergen tropomyosin inhibits shrimp tropomyosin specific IgE reactivity. PLoS One 9:e111649. https://doi.org/10.1371/journal.pone.0111649 CrossRefPubMedPubMedCentral

150.

Ayuso R, Lehrer SB, Reese G (2002) Identification of continuous, allergenic regions of the major shrimp allergen Pen a 1 (tropomyosin). Int Arch Allergy Immunol 127:27-37. doi:48166 [pii] 48166

151.

Garcia-Casado G, Pacios LF, Diaz-Perales A, Sanchez-Monge R, Lombardero M, Garcia-Selles FJ, Polo F, Barber D, Salcedo G (2003) Identification of IgE-binding epitopes of the major peach allergen Pru p 3. J Allergy Clin Immunol 112:599–605CrossRefPubMed

152.

King N, Helm R, Stanley JS et al (2005) Allergenic characteristics of a modified peanut allergen. Mol Nutr Food Res 49:963–971. https://doi.org/10.1002/mnfr.200500073 CrossRefPubMed

153.

Lam YF, Tong KK, Kwan KM, Tsuneyama K, Shu SA, Leung PS, Chu KH (2015) Gastrointestinal immune response to the shrimp allergen tropomyosin: histological and immunological analysis in an animal model of shrimp tropomyosin hypersensitivity. Int Arch Allergy Immunol 167:29–40. https://doi.org/10.1159/000431228 CrossRefPubMed

154.

Leung PSC, Lee YS, Tang CY, Kung WY, Chuang YH, Chiang BL, Fung MC, Chu KH (2008) Induction of shrimp tropomyosin-specific hypersensitivity in mice. Int Arch Allergy Immunol 147:305–314. https://doi.org/10.1159/000144038 CrossRefPubMed

155.

Singh A, Holvoet S, Mercenier A (2011) Dietary polyphenols in the prevention and treatment of allergic diseases. Clin Exp Allergy 41:1346–1359. https://doi.org/10.1111/j.1365-2222.2011.03773.x CrossRefPubMed

156.

Plundrich NJ, Kulis M, White BL, Grace MH, Guo R, Burks AW, Davis JP, Lila MA (2014) Novel strategy to create hypoallergenic peanut protein-polyphenol edible matrices for oral immunotherapy. J Agric Food Chem 62:7010–7021. https://doi.org/10.1021/jf405773b CrossRefPubMed

157.

Zuidmeer-Jongejan L, Fernandez-Rivas M, Poulsen LK et al (2012) FAST: towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies. Clin Transl Allergy 2:5. https://doi.org/10.1186/2045-7022-2-5 CrossRefPubMedPubMedCentral

158.

Swoboda I, Bugajska-Schretter A, Linhart B et al. (2007) A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy. J Immunol 178:6290-6296. doi:178/10/6290 [pii]

159.

Zuidmeer-Jongejan L, Huber H, Swoboda I et al (2015) Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy. Int Arch Allergy Immunol 166:41–51. https://doi.org/10.1159/000371657 CrossRefPubMed

160.

Freidl R, Gstoettner A, Baranyi U et al (2017) Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy. J Allergy Clin Immunol 139(1897-1905):e1891. https://doi.org/10.1016/j.jaci.2016.10.018 CrossRef

161.

Larche M (2011) T cell epitope-based allergy vaccines. Curr Top Microbiol Immunol 352:107–119. https://doi.org/10.1007/82_2011_131 CrossRefPubMed

162.

Prickett SR, Rolland JM, O’Hehir RE (2015) Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy. Clin Exp Allergy 45:1015–1026. https://doi.org/10.1111/cea.12554 CrossRefPubMedPubMedCentral

163.

Meulenbroek LA, van Esch BC, Hofman GA et al (2013) Oral treatment with beta-lactoglobulin peptides prevents clinical symptoms in a mouse model for cow’s milk allergy. Pediatr Allergy Immunol 24:656–664. https://doi.org/10.1111/pai.12120 CrossRefPubMed

164.

Thang CL, Zhao X (2015) Effects of orally administered immunodominant T-cell epitope peptides on cow’s milk protein allergy in a mouse model. Food Res Int 71:126–131CrossRef

165.

Yang M, Mine Y (2009) Novel T-cell epitopes of ovalbumin in BALB/c mouse: potential for peptide-immunotherapy. Biochem Biophys Res Commun 378:203–208. https://doi.org/10.1016/j.bbrc.2008.11.037 CrossRefPubMed

166.

Mizumachi K, Kurisaki J (2003) Localization of T cell epitope regions of chicken ovomucoid recognized by mice. Biosci Biotechnol Biochem 67:712–719CrossRefPubMed

167.

Yang M, Yang C, Mine Y (2010) Multiple T cell epitope peptides suppress allergic responses in an egg allergy mouse model by the elicitation of forkhead box transcription factor 3- and transforming growth factor-beta-associated mechanisms. Clin Exp Allergy 40:668–678. https://doi.org/10.1111/j.1365-2222.2009.03442.x CrossRefPubMed

168.

Rupa P, Mine Y (2012) Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy. Allergy 67:74–82. https://doi.org/10.1111/j.1398-9995.2011.02724.x CrossRefPubMed

169.

Wai CYY, Leung NYH, Leung PSC, Chu KH (2016) T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy. Clin Exp Allergy 46:491–503. https://doi.org/10.1111/cea.12684 CrossRefPubMed

170.

Ravkov EV, Pavlov IY, Martins TB, Gleich GJ, Wagner LA, Hill HR, Delgado JC (2013) Identification and validation of shrimp-tropomyosin specific CD4 T cell epitopes. Hum Immunol 74:1542–1549. https://doi.org/10.1016/j.humimm.2013.08.276 CrossRefPubMed

171.

Clark AT, Islam S, King Y, Deighton J, Anagnostou K, Ewan PW (2009) Successful oral tolerance induction in severe peanut allergy. Allergy 64:1218–1220. https://doi.org/10.1111/j.1398-9995.2009.01982.x CrossRefPubMed

172.

Patil SU, Ogunniyi AO, Calatroni A, Tadigotla VR, Ruiter B, Ma A, Moon J, Love JC, Shreffler WG (2015) Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects. J Allergy Clin Immunol 136:125–134. https://doi.org/10.1016/j.jaci.2015.03.026 CrossRefPubMedPubMedCentral

173.

Syed A, Garcia MA, Lyu SC et al (2014) Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol 133:500–510. https://doi.org/10.1016/j.jaci.2013.12.1037 CrossRefPubMedPubMedCentral

174.

Nowak-Wegrzyn A, Albin S (2015) Oral immunotherapy for food allergy: mechanisms and role in management. Clin Exp Allergy 45:368–383. https://doi.org/10.1111/cea.12382 CrossRefPubMed

175.

Pascal M, Konstantinou GN, Masilamani M, Lieberman J, Sampson HA (2013) In silico prediction of Ara h 2 T cell epitopes in peanut-allergic children. Clin Exp Allergy 43:116–127. https://doi.org/10.1111/cea.12014 CrossRefPubMed

176.

Prickett SR, Voskamp AL, Dacumos-Hill A, Symons K, Rolland JM, O’Hehir RE (2011) Ara h 2 peptides containing dominant CD4+ T-cell epitopes: candidates for a peanut allergy therapeutic. J Allergy Clin Immunol 127:608–615. https://doi.org/10.1016/j.jaci.2010.09.027 CrossRefPubMed

177.

Prickett SR, Voskamp AL, Phan T, Dacumos-Hill A, Mannering SI, Rolland JM, O’Hehir RE (2013) Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic. Clin Exp Allergy 43:684–697. https://doi.org/10.1111/cea.12113 CrossRefPubMedPubMedCentral

178.

Meulenbroek LA, den Hartog Jager CF, Lebens AF, Knulst AC, Bruijnzeel-Koomen CA, Garssen J, Knippels LM, van Hoffen E (2014) Characterization of T cell epitopes in bovine alpha-lactalbumin. Int Arch Allergy Immunol 163:292–296. https://doi.org/10.1159/000360733 CrossRefPubMed

179.

Ruiter B, Tregoat V, M’Rabet L, Garssen J, Bruijnzeel-Koomen CA, Knol EF, Hoffen E (2006) Characterization of T cell epitopes in alphas1-casein in cow’s milk allergic, atopic and non-atopic children. Clin Exp Allergy 36:303–310. https://doi.org/10.1111/j.1365-2222.2006.02436.x CrossRefPubMed

180.

Pastorello EA, Monza M, Pravettoni V, Longhi R, Bonara P, Scibilia J, Primavesi L, Scorza R (2010) Characterization of the T-cell epitopes of the major peach allergen Pru p 3. Int Arch Allergy Immunol 153:1–12. https://doi.org/10.1159/000301573 CrossRefPubMed

181.

Tordesillas L, Cuesta-Herranz J, Gonzalez-Munoz M, Pacios LF, Compes E, Garcia-Carrasco B, Sanchez-Monge R, Salcedo G, Diaz-Perales A (2009) T-cell epitopes of the major peach allergen, Pru p 3: identification and differential T-cell response of peach-allergic and non-allergic subjects. Mol Immunol 46:722–728. https://doi.org/10.1016/j.molimm.2008.10.018 CrossRefPubMed

182.

Schulten V, Radakovics A, Hartz C et al (2009) Characterization of the allergic T-cell response to Pru p 3, the nonspecific lipid transfer protein in peach. J Allergy Clin Immunol 124:100–107. https://doi.org/10.1016/j.jaci.2009.02.010 CrossRefPubMed

183.

Nielsen M, Lund O, Buus S, Lundegaard C (2010) MHC class II epitope predictive algorithms. Immunology 130:319–328. https://doi.org/10.1111/j.1365-2567.2010.03268.x CrossRefPubMedPubMedCentral

184.

Yang M, Yang C, Nau F, Pasco M, Juneja LR, Okubo T, Mine Y (2009) Immunomodulatory effects of egg white enzymatic hydrolysates containing immunodominant epitopes in a BALB/c mouse model of egg allergy. J Agric Food Chem 57:2241–2248. https://doi.org/10.1021/jf803372b CrossRefPubMed

185.

Kulis M, Macqueen I, Li Y, Guo R, Zhong XP, Burks AW (2012) Pepsinized cashew proteins are hypoallergenic and immunogenic and provide effective immunotherapy in mice with cashew allergy. J Allergy Clin Immunol 130:716–723. https://doi.org/10.1016/j.jaci.2012.05.044 CrossRefPubMed

186.

Suphioglu C, Schappi G, Kenrick J, Levy D, Davies JM, O’Hehir RE (2001) A novel grass pollen allergen mimotope identified by phage display peptide library inhibits allergen-human IgE antibody interaction. FEBS Lett 502:46–52CrossRefPubMed

187.

Ganglberger E, Grunberger K, Wiedermann U, Vermes M, Sponer B, Breiteneder H, Scheiner O, Boltz G, Jensen-Jarolim E (2001) IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice. Int Arch Allergy Immunol 124:395-397. doi:53768 [pii] 53768

188.

Ganglberger E, Grunberger K, Sponer B, Radauer C, Breiteneder H, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E (2000) Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE. FASEB J 14:2177–2184. https://doi.org/10.1096/fj.99-1000com CrossRefPubMed

189.

Jensen-jarolim E, Leitner A, Kalchhauser H, Zurcher A, Ganglberger E, Bohle B, Scheiner O, Boltz-nitulescu G, Breiteneder H (1998) Peptide mimotopes displayed by phage inhibit antibody binding to bet v 1, the major birch pollen allergen, and induce specific IgG response in mice. FASEB J 12:1635–1642CrossRefPubMed

190.

Hantusch B, Krieger S, Untersmayr E et al (2004) Mapping of conformational IgE epitopes on Phl p 5a by using mimotopes from a phage display library. J Allergy Clin Immunol 114:1294–1300. https://doi.org/10.1016/j.jaci.2004.06.048 CrossRefPubMed

191.

Pacios LF, Tordesillas L, Cuesta-Herranz J, Compes E, Sanchez-Monge R, Palacin A, Salcedo G, Diaz-Perales A (2008) Mimotope mapping as a complementary strategy to define allergen IgE-epitopes: peach Pru p 3 allergen as a model. Mol Immunol 45:2269–2276. https://doi.org/10.1016/j.molimm.2007.11.022 CrossRefPubMed

192.

Untersmayr E, Szalai K, Riemer AB et al (2006) Mimotopes identify conformational epitopes on parvalbumin, the major fish allergen. Mol Immunol 43:1454–1461. https://doi.org/10.1016/j.molimm.2005.07.038 CrossRefPubMed

193.

Szalai K, Jensen-Jarolim E, Pali-Scholl I (2008) Vaccination strategies based on the mimotope concept. G Ital Dermatol Venereol 143:95–104PubMed

194.

Tiwari R, Negi SS, Braun B, Braun W, Pomes A, Chapman MD, Goldblum RM, Midoro-Horiuti T (2012) Validation of a phage display and computational algorithm by mapping a conformational epitope of Bla g 2. Int Arch Allergy Immunol 157:323–330. https://doi.org/10.1159/000330108 CrossRefPubMed

195.

Wallmann J, Epstein MM, Singh P, Brunner R, Szalai K, El-Housseiny L, Pali-Scholl I, Jensen-Jarolim E (2010) Mimotope vaccination for therapy of allergic asthma: anti-inflammatory effects in a mouse model. Clin Exp Allergy 40:650–658. https://doi.org/10.1111/j.1365-2222.2009.03392.x CrossRefPubMed

196.

Leung NYH, Wai CYY, Ho MH, Liu R, Lam KS, Wang JJ, Shu SA, Chu KH, Leung PSC (2017) Screening and identification of mimotopes of the major shrimp allergen tropomyosin using one-bead-one-compound peptide libraries. Cell Mol Immunol 14:308–318. https://doi.org/10.1038/cmi.2015.83 CrossRefPubMed

197.

Zhou Y, Kawasaki H, Hsu SC et al (2010) Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat Med 16:1128–1133. https://doi.org/10.1038/nm.2201 CrossRefPubMedPubMedCentral

198.

Schulke S, Burggraf M, Waibler Z, Wangorsch A, Wolfheimer S, Kalinke U, Vieths S, Toda M, Scheurer S (2011) A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy. J Allergy Clin Immunol 128:1340–1348. https://doi.org/10.1016/j.jaci.2011.07.036 CrossRefPubMed

199.

Liu Y, Sun Y, Chang LJ et al (2013) Blockade of peanut allergy with a novel Ara h 2-Fcgamma fusion protein in mice. J Allergy Clin Immunol 131:213–221. https://doi.org/10.1016/j.jaci.2012.10.018 CrossRefPubMed

200.

Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD (2014) A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease. ACS Nano 8:2148–2160. https://doi.org/10.1021/nn405033r CrossRefPubMedPubMedCentral

201.

Srivastava KD, Siefert A, Fahmy TM, Caplan MJ, Li XM, Sampson HA (2016) Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy. J Allergy Clin Immunol 138:536–543. https://doi.org/10.1016/j.jaci.2016.01.047 CrossRefPubMed

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Immunotherapy of Food Allergy: a Comprehensive Review

Abstract

Neu im Fachgebiet HNO

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Update HNO

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Regional Differences in Food Allergies

Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications

Cashew Nut Allergy: Clinical Relevance and Allergen Characterisation

A Comprehensive Review on Mustard-Induced Allergy and Implications for Human Health